Strong R&D leads to strong products
Kuopio has a solid track record in gene technology research, and one that has led to several spin-offs. The development of the world’s first transgenic heifers has been followed by several commercial applications, such as POC virus diagnostics and dnaArray diagnostics.
The latest application to follow this path has been gene-based medication. Basic biomedical research at the University of Kuopio laid the foundation for the birth of Ark Therapeutics, now listed on the London Stock Exchange. Ark Therapeutics has recently been granted a licence from the EMEA (European Medicines Agency) to launch the world’s first gene-based medicine manufacturing unit, to be located in the Teknia Microteknia 4 building.
Kuopio Science Park is home to a unique combination of skills and expertise in the fields of health, nutrition, and the environmental sciences, as well as information and communications technology.
More than 15,000 people work or study in the Park, which houses the University of Kuopio, Kuopio University Hospital, Teknia, Savonia Polytechnic, the Neulanen Research Centre, the Kuopio Regional Office of the Geological Survey of Finland, as well as over 190 companies.
Teknia plays an important role in encouraging business development in eastern Finland, thanks to its unique R&D skills, custom-built facilities, and wide range of services for promoting the start-up of new business activities. Valuable input is provided by Teknia’s participation in a network of national and international organisations.
In Finland, these include the Finnish Science Park Association (TEKEL), the Pharmaceutical Cluster of Finland, and Finnish Bioindustry (FIB). Internationally, Teknia’s partners include the International Association of Science Parks (IASP) and the International Relay Centre (IRC).
Teknia’s strategic partners in Asia include the Shanghai Pudong New District Government, the Zhangjiang Hi-Tech Park, the Shanghai Innovative Research Center of Traditional Chinese Medicine, the Shanghai University of Traditional Chinese Medicine, Shanghai International Medical Zone, and the Hong Kong Science and Technology Park.
In Europe, Teknia’s partners include the University of Surrey in Britain, Teknikbyn Västerås Technology Park in Sweden, and Gesellschaft für Technologieförderung Itzehoe mbH Izet in Germany. In the US, Teknia works with the Minnesota University Enterprise Laboratories.